NO20005498L - Form of 1- (6-chloro naphth-2-surface sulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size - Google Patents

Form of 1- (6-chloro naphth-2-surface sulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size

Info

Publication number
NO20005498L
NO20005498L NO20005498A NO20005498A NO20005498L NO 20005498 L NO20005498 L NO 20005498L NO 20005498 A NO20005498 A NO 20005498A NO 20005498 A NO20005498 A NO 20005498A NO 20005498 L NO20005498 L NO 20005498L
Authority
NO
Norway
Prior art keywords
naphth
piperazine
sulfonyl
pyridyl
benzoyl
Prior art date
Application number
NO20005498A
Other languages
Norwegian (no)
Other versions
NO20005498D0 (en
Inventor
Marianne Ashford
Roger James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005498D0 publication Critical patent/NO20005498D0/en
Publication of NO20005498L publication Critical patent/NO20005498L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20005498A 1998-05-02 2000-11-01 Form of 1- (6-chloro naphth-2-surface sulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size NO20005498L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (2)

Publication Number Publication Date
NO20005498D0 NO20005498D0 (en) 2000-11-01
NO20005498L true NO20005498L (en) 2000-11-01

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005498A NO20005498L (en) 1998-05-02 2000-11-01 Form of 1- (6-chloro naphth-2-surface sulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size

Country Status (16)

Country Link
EP (1) EP1084118A1 (en)
JP (1) JP2002513789A (en)
KR (1) KR20010043216A (en)
CN (1) CN1308629A (en)
AU (1) AU3719699A (en)
BR (1) BR9910176A (en)
CA (1) CA2331041A1 (en)
EE (1) EE200000638A (en)
GB (1) GB9809350D0 (en)
HU (1) HUP0102394A3 (en)
IL (1) IL139405A0 (en)
NO (1) NO20005498L (en)
PL (1) PL343705A1 (en)
SK (1) SK16522000A3 (en)
WO (1) WO1999057112A1 (en)
ZA (1) ZA200006036B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010015639A (en) 1997-09-30 2001-02-26 스즈키 다다시 Sulfonyl derivatives
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (en) * 1996-11-08 2003-05-15 Зенека Лімітед Heterocyclic derivatives
WO1998054164A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
KR20010015639A (en) * 1997-09-30 2001-02-26 스즈키 다다시 Sulfonyl derivatives

Also Published As

Publication number Publication date
NO20005498D0 (en) 2000-11-01
IL139405A0 (en) 2001-11-25
BR9910176A (en) 2001-01-09
JP2002513789A (en) 2002-05-14
HUP0102394A2 (en) 2001-12-28
EE200000638A (en) 2002-04-15
AU3719699A (en) 1999-11-23
GB9809350D0 (en) 1998-07-01
PL343705A1 (en) 2001-08-27
ZA200006036B (en) 2002-01-25
WO1999057112A1 (en) 1999-11-11
CN1308629A (en) 2001-08-15
EP1084118A1 (en) 2001-03-21
SK16522000A3 (en) 2001-05-10
HUP0102394A3 (en) 2003-01-28
KR20010043216A (en) 2001-05-25
CA2331041A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
HK5288A (en) 2-[4-[(4,4-dialkyl-2, 6-piperidinedion-1-yl) butyl]-1-piperazinyl]pyrimidines
NO20015746D0 (en) New use of 1- [4- (5-cyanindol-3-yl) butyl] -4- (2-carbamoylbenzofuran-5-yl) -piperazine and its physiologically acceptable salts
NO924764L (en) 4-PYRIMIDINYL AND PYRIDINYL DERIVATIVES OF INDOL-3-YL ALKYL PIPERAZINE
DE60125980D1 (en) P38 KINASE INHIBITORS OF THE PIPERIDINE / PIPERAZINE TYPE
NO20000115D0 (en) Gastro-kinetic monocyclic benzamides of 3- or 4- substituted 4- (aminomethyl) -piperidine derivatives
DE60142613D1 (en) ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINES AND TRIAZINES AND THEIR USE
NO940881L (en) Enantiomers of 1 - [(4-chlorophenyl) phenylmethyl] -4 - [(4-methylphenyl) sulfonyl] piperazine
CH1175401H1 (en) Piperazine derivatives useful as CCR5 antagonists
NO984380D0 (en) New piperazine and piperidine compounds
EE200300007A (en) Heterocyclic derivatives of tetrahydropyridine or piperidine
FI964815L (en) Piperazine derivatives as 5-HT1A antagonists
EE200100498A (en) 1,4-substituted piperazine, 1,4-substituted piperidine and 1-substituted 4-alkylidenylpiperidine compounds and their therapeutic uses
DE69731094D1 (en) MESYLATE DIHYDRATE SALTS of 5- (2- (4- (1,2-BENZISOTHIAZOL-3-yl) -1-PIPERAZINYL) -ETHYL) -6-CHLORO-1,3-DIHYDRO-2 (1H) -INDOL-2-ON (= ZIPRASIDONE), THE PRODUCTION AND USE THEREOF AS A DOPAMINE D2 ANTAGONIST
MX9305027A (en) 4- 2- (4- (2-PIRIDINILOXI) FENYL) ETOXI] QUINAZOLINE AND ANALOGOS OF THE SAME.
ES8402832A1 (en) 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
ATE116316T1 (en) ANTIPSYCHOTIC 4-(1,2-BENZISOAZOLYL)PIPERIDINE DERIVATIVES.
ATE196294T1 (en) PIPERAZINE DERIVATIVES AND THEIR USE AS 5-HT1A ANTAGONISTS
NO20005498L (en) Form of 1- (6-chloro naphth-2-surface sulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size
NO894650D0 (en) PROCESS FOR THE PREPARATION OF 2- (2- (4 - (((4-CHLORPHENYL) -PHENYLMETHYL) -PIPERAZINYL) -ETHOXY) -ACDIC ACID AND ITS DIHYDROCHLORIDE.
NO20013832D0 (en) Piperidine and piperazine derivatives as inhibitors of Abeta fibril formation
NO20002631L (en) Pseudopolymorphic forms of 2- [2- [4- (bis (4-fluorophenyl) methyl] -1-piperazinyl] ethoxy] acetic acid dihydrochloride
ATE525362T1 (en) 2-(3-(4-(2-T-BUTYL-6-TRIFLUORMETHYLPYRIMIDINE-4-
FI964114L (en) New crystalline forms of 1-(5-methanesulfonamidoindolyl-2-carbonyl)-4-(3-(1-methylethylamino)-2-pyridinyl)piperazine
DE60204791D1 (en) SYNTHESIS OF 4- (PIPERIDYL) (2-PYRIDYL) METHANONE- (E) -O-METHYLOXIM AND ITS SALTS
AU3793478A (en) 4-[4-(2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl-methyl)-1-piperazinyl]-6-methyl pyrimidine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application